 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/09/2018 |
$94.71 |
$95.26 |
$93.80 |
$94.57 |
3.63M | | 10/10/2018 |
$93.85 |
$95.39 |
$92.99 |
$93.08 |
5.31M | | 10/11/2018 |
$93.00 |
$93.38 |
$89.61 |
$90.70 |
9.99M | | 10/12/2018 |
$90.71 |
$91.08 |
$88.90 |
$90.69 |
5.71M | | 10/15/2018 |
$90.51 |
$90.60 |
$89.18 |
$89.18 |
4.83M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on October 09, 2018, ABBV opened at $94.71, traded as high as $95.26 and as low as $93.80, and closed at $94.57. Trading volume was a total of 3.63M shares. On October 10, 2018, ABBV opened at $93.85, traded as high as $95.39 and as low as $92.99, and closed at $93.08. Trading volume was a total of 5.31M shares. On October 11, 2018, ABBV opened at $93.00, traded as high as $93.38 and as low as $89.61, and closed at $90.70. Trading volume was a total of 9.99M shares. On October 12, 2018, ABBV opened at $90.71, traded as high as $91.08 and as low as $88.90, and closed at $90.69. Trading volume was a total of 5.71M shares. On October 15, 2018, ABBV opened at $90.51, traded as high as $90.60 and as low as $89.18, and closed at $89.18. Trading volume was a total of 4.83M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
10/15/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$89.18 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
353.61 |
|
| Dividends reinvested/share: |
$13.71 |
|
| Total return: |
215.35% |
|
| Average Annual Total Return: |
21.97% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$31,539.13 |
|
| Years: |
5.78 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
10/15/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$89.18 |
|
| Dividends collected/share: |
$13.71 |
|
| Total return: |
192.97% |
|
| Average Annual Total Return: |
20.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,290.41 |
|
| Years: |
5.78 |
|
|
|
| Date |
Close |
| 10/09/2018 | $94.57 | | 10/10/2018 | $93.08 | | 10/11/2018 | $90.70 | | 10/12/2018 | $90.69 | | 10/15/2018 | $89.18 |
|
|
